The global microcatheters market is strongly driven by forces guided by a rise in increasing chronic disorders among the advanced population related to cardiovascular, neurovascular, and cancerous conditions. The key players are covered in the report with their sales, revenues and strategies are Medtronic Plc., Terumo Corporation, Merit Medical Systems, Stryker Corporation, Penumbra Inc., Boston Scientific Corporation, Teleflex Inc., ASAHU INTECC CO. LTD., Cook Group International, Becton, Dickinson and Company, AngioDynamics Inc., and B. Braun Melsungen, among others.
NEW YORK, United States, Oct. 05, 2022 (GLOBE NEWSWIRE) -- According to Facts and Factors has published a new research report titled “Microcatheters Market By Design (Single Lumen & Dual Lumen), By Type (Delivery Microcatheter, Aspiration Microcatheter, Diagnostic Microcatheter, & Steerable Microcatheter), By Application (Cardiology, Neurology, Peripheral Vascular, Oncology, Urology, Otolaryngology, & Others), By End-User (Hospitals, Surgical Centers, Specialty Clinics, and Ambulatory Care Centers), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2020 – 2026” in its research database.
“According to the latest research study, the demand of global Microcatheters Market size & share in terms of revenue was worth of USD 760 Million in 2020 and it is expected to surpass around USD 1,800 Million mark by 2026, growing at a compound annual growth rate (CAGR) of approximately 8.2% during the forecast period 2021 to 2026.”
Microcatheters are an astute form of catheters that usually range from a diameter range of 0.7 – 1.3 mm in diameter. These devices are usually used for delivering objects to and fro in the human body as well as provide guidewire support, access certain anatomies, inject therapeutic consumables, and providing certain injectables for further medical procedures. The major driving forces behind the significant growth of microcatheters can be credited to the rise in chronic diseases among the aging population as well as disorders relating to cardiovascular, neurovascular, and cancerous conditions.
Additional factors that credit the rise of microcatheters include improved features such as decreased failure rates and procedural times and the real-time ability to change the degree of angulation. Moreover, a litany of efforts from the combination of government bodies and global organizations to exchange valuable information about the advantages of microcatheters will further propel the growth of the market during the forecast.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.fnfresearch.com/sample/microcatheters-market
(A free sample of this report is available upon request; please contact us for more information.)
Medtronic Plc., Terumo Corporation, Merit Medical Systems, Stryker Corporation, Penumbra, Inc., Boston Scientific Corporation, Teleflex, Inc., ASAHU INTECC CO. LTD., Cook Group International, Becton, Dickinson and Company, AngioDynamics, Inc., and B. Braun Melsungen, among others.
By Design, Type, End-User, Application, and Region
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa
Request customized purchase options to meet your research needs.
The global microcatheters market is strongly driven by forces guided by a rise in increasing chronic disorders among the advanced population related to cardiovascular, neurovascular, and cancerous conditions coupled with the rising adoption of minimally invasive procedures. Additional factors that can be credited to the drastic rise in microcatheters are advancements in technology along with increased government incentives. Moreover, a rapid change in the sedimentary lifestyle pertains to an increase in habits such as smoking cigarettes, hypertension, and obesity-related disorders will further boost the growth of the microcatheters market to a significant rate.
Advancements in technology such as the rise of use for steerable microcatheters will further augment the market development. Advanced features in the latest iteration of microcatheters such as a reduced failure rate, decrease in procedural time and the real-time ability to change the degree of angulation will open opportunities for the microcatheter market to flourish during the forecast period. Additionally, collaborative efforts from the global organizations and improved medical infrastructure are expected to push the market of microcatheters towards a ballooned state during the forecast.
Browse the full “Microcatheters Market By Design (Single Lumen & Dual Lumen), By Type (Delivery Microcatheter, Aspiration Microcatheter, Diagnostic Microcatheter, & Steerable Microcatheter), By Application (Cardiology, Neurology, Peripheral Vascular, Oncology, Urology, Otolaryngology, & Others), By End-User (Hospitals, Surgical Centers, Specialty Clinics, and Ambulatory Care Centers), And By Regions - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2020 – 2026” Report at https://www.fnfresearch.com/microcatheters-market
The global microcatheters market can be segmented on the basis of type, design, end-user, applications, and regions.
The global microcatheters market can be broken down into single lumen and dual-lumen microcatheter on the basis of design. The dual lumen microcatheters are expected to witness the highest market share during the forecast period. The latter segment recouped around 70% of the market share during the last iteration of the forecast. The dominant position by the segment can be attributed to the numerous advantages it offers over its counterpart such as easy access to the mentioned site, the ability to tune more than one analgesic infusion during the procedure, and the preferred device to be used for a variety of interventional cardiology procedures. The global microcatheters market can be disintegrated into delivery, aspiration, diagnostic, and steerable microcatheter on the basis of type.
Aspiration microcatheters are expected to dominate the market during the forecast period owing to an increased demand for acute stroke, aneurysms, and peripheral artery-based disorders. Aspiration-based microcatheters also offer additional feasibility such as rapid recanalization, total stoppage of blood flow, and improved preventative abilities for embolism-like conditions during operations. The global microcatheters market can be broken down into cardiology, neurology, peripheral vascular, oncology, urology, otolaryngology, and others. The cardiology segment is expected to dominate the market in terms of revenue during the forecast period owing to the worldwide trend of increase of cardiovascular-related disorders and conditions.
However, the neurology segment will witness the fastest growing CAGR owing to the second and third most cause of disability-related conditions. Based on the end-user, the market is categorized into Hospitals, Surgical Centers, Specialty Clinics, and ambulatory care centers. The hospital category accounted for the largest market share due to the rise in the number of hospitals and specialty clinics in developing nations; the growing prevalence of target diseases, and also a surge in the performance of surgical and diagnostic procedures across these facilities.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/microcatheters-market
The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards. Some of the main competitors dominating the global Microcatheters market include -
Key Insights from Primary Research:
As per the analysis shared by our research analyst, the Microcatheters market is estimated to grow annually at a CAGR of around 8.2% over the forecast period (2021-2026).
In Terms Of Revenue, The Microcatheters market size was valued at around US$ 760 Million in 2020 and is projected to reach US$ 1,800 Million by 2026. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
The hospital category represented the end-user segment that was responsible for the biggest market share.
The cardiology market segment is expected to have the biggest share of the market based on how it will be used.
During the period covered by this forecast, the market share in North America will expand at a rate that is highest among other regions.
Market Size & Forecast by Revenue | 2021−2026
Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
Market Segmentation – A detailed analysis By Design, Type, End-User, Application, and Region
Competitive Landscape – Top Key Vendors and Other Prominent Vendors
North America is expected to witness the largest market share during the forecast period owing to a litany of factors pertaining to better healthcare establishments, increased healthcare spending among consumers, widened government incentives, raising awareness among consumers, and better healthcare infrastructures. The region of Asia-Pacific is expected to witness the fastest CAGR during the forecast owing to various crediting factors such as an increasing in the aging population in emerging economies such as Japan, China, and India. Additional factors for the significant rise in the region can be accredited towards improved healthcare facilities and increased consumer spending.
The region of Japan (ASAHI INTECC CO. LTD.) recently collaborated with a firm of the United States (Medtronic Plc.) to introduce a range of guidewire catheters in the region.
Merit Medical Systems, Inc. collaborated with Argon Medical Devices and Catheter Connections, Inc. in order to extend its product range.
Merit Medical Systems, Inc. furthers the FDA’s approval for SwiftNINJA steerable range of microcatheters.
Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/microcatheters-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
The global Microcatheters market is segmented as follows:
The Middle East & Africa
Rest of the Middle East & Africa
Browse Other Related Research Reports from Facts & Factors:
Medical Device Market: https://www.fnfresearch.com/medical-device-market
Menstrual Cups Market: https://www.fnfresearch.com/menstrual-cups-market
Medical Ventilator Market: https://www.fnfresearch.com/medical-ventilator-market-by-mobility-intensive-care-portable-1278
Medical Gases and Equipment Market: https://www.fnfresearch.com/medical-gases-and-equipment-market-by-type-medical-1277
Nasal Filters Market: https://www.fnfresearch.com/nasal-filters-market-by-type-filter-changeable-type-1269
Orthopedic Trauma Devices Market: https://www.fnfresearch.com/global-orthopedic-trauma-devices-market-by-product-type-1220
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
USA: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 73877 19999
Email: sales@fnfresearch.com | Web: https://www.fnfresearch.com
Follow Us on - LinkedIn | Twitter | Facebook
Oil prices have bounced around quite a bit this year. Brent oil, the global-pricing benchmark, started 2022 below $80 a barrel before soaring into the $120s following Russia's invasion of Ukraine. With the prospect of higher oil prices, we asked some of our energy contributors what oil stocks they believe are best positioned to capitalize following OPEC's bold move.
Intel (NASDAQ: INTC) has been under tremendous pressure this year. Shares of the semiconductor company have tumbled about 50%. While Intel is facing its share of headwinds, I believe better days lie ahead for the tech giant and its big-time dividend.
The three stocks that stood out to me are Taiwan Semiconductor (NYSE: TSM), Disney (NYSE: DIS), and Adobe (NASDAQ: ADBE). The company is a third-party manufacturer for chip leaders like Apple (NASDAQ: AAPL), Nvidia (NASDAQ: NVDA), and dozens of other companies designing their own chips.
Tax-loss harvesting has risen in popularity. BofA says the strategy could give a boost to underperforming stocks from November to January.
The year 2022 has been a painful journey for semiconductor manufacturers. Following the example of AMD , Nvidia and Intel , which are the three main players in the sector, 2022 is a year to forget .Their valuations are in recession. Advanced Micro Devices (AMD) currently has a market value of $94.4 billion, which is a decrease of at least $83 billion compared to December 31, 2021.
The veteran telecom company is having a stellar year in many respects, but reason for concern has emerged.
Investing in Warren Buffett's biggest holdings can be a winning tactic, but don't overlook the companies that occupy smaller positions in Berkshire Hathaway's portfolio.
You would think this would be TIPS’ time to shine. Instead, the prices of Treasury inflation-protected securities—government bonds that are adjusted to keep up with inflation—have declined this year, even as inflation has soared. The comparable loss for ICE’s index of regular Treasury bonds was 13.5%.
PayPal is in trouble. "You are independently responsible for complying with all applicable laws in all of your actions related to your use of PayPal's services, regardless of the purpose of the use," the document, called "Acceptable Use of Policy," said.
NIO Inc. stock is trending on the Yahoo Finance Platform. Here is a visualization of $NIO performance over time, how that performance compares to the wider industry, and analyst projections for the current quarter.Check out the ticker page here.
This indicator has correctly predicted five steep stock market declines since 1870 -- and it's highly successful at calling bottoms, too!
If you buy one between now and the end of October, you’ll earn a composite interest rate of 9.62%.
For the retail investor, the only certainty of our current market environment is uncertainty. Volatility is up, and the main indexes are showing deepening losses. As if that wasn't enough, at least one market bull is turning a bit more pessimistic. JPMorgan strategist Marko Kolanovic has been one of the more bullish voices on Wall Street in recent months, but current conditions have him pushing the timeline back. While he still believes that the S&P 500 can hit 4,800, or a 32% gain from current
Luckily for everyday investors like us, institutions that trade stocks need to disclose their transactions to the Securities and Exchange Commission every three months. Ray Dalio's hedge fund, Bridgewater Associates, made a relatively large bet on CVS Health (NYSE: CVS) stock in the second quarter. It's CVS' less visible business segments that have allowed it to more than triple its dividend payout over the past decade.
The company's longtime CEO announced his retirement, leading some analysts to contemplate a cut to the 14% dividend.
The first quarter of 2022 has been difficult for retirement savers and retirees alike, and according to investment firm Charles Schwab, it was one of the worst quarters for fixed-income in decades. However, the rising yields and changed Federal Reserve … Continue reading → The post Charles Schwab Says Now Is the Time to Add This Asset to Your Retirement Portfolio appeared first on SmartAsset Blog.
It may not be practical — at least for now.
A market rally attempt is reeling as the indexes plunged on Friday's jobs report. Tesla, AMD and On Semi sold off.
The company is reaping benefits from investments in 5G technology, but that's not necessarily enough to make AT&T stock a buy.
Should I buy stocks now or wait? That's a question many investors are asking themselves right now.